232 related articles for article (PubMed ID: 29911923)
21. miR-125b and miR-532-3p predict the efficiency of rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A French Innovative Leukemia Organization study.
Gagez AL; Duroux-Richard I; Leprêtre S; Orsini-Piocelle F; Letestu R; De Guibert S; Tuaillon E; Leblond V; Khalifa O; Gouilleux-Gruart V; Banos A; Tournilhac O; Dupuis J; Jorgensen C; Cartron G; Apparailly F
Haematologica; 2017 Apr; 102(4):746-754. PubMed ID: 28126961
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia.
Cui B; Chen L; Zhang S; Mraz M; Fecteau JF; Yu J; Ghia EM; Zhang L; Bao L; Rassenti LZ; Messer K; Calin GA; Croce CM; Kipps TJ
Blood; 2014 Jul; 124(4):546-54. PubMed ID: 24914134
[TBL] [Abstract][Full Text] [Related]
23. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
[TBL] [Abstract][Full Text] [Related]
24. Downregulated miR-17, miR-29c, miR-92a and miR-214 may be related to BCL11B overexpression in T cell acute lymphoblastic leukemia.
He Z; Liao Z; Chen S; Li B; Yu Z; Luo G; Yang L; Zeng C; Li Y
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e259-e265. PubMed ID: 29749698
[TBL] [Abstract][Full Text] [Related]
25. microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival.
Rossi S; Shimizu M; Barbarotto E; Nicoloso MS; Dimitri F; Sampath D; Fabbri M; Lerner S; Barron LL; Rassenti LZ; Jiang L; Xiao L; Hu J; Secchiero P; Zauli G; Volinia S; Negrini M; Wierda W; Kipps TJ; Plunkett W; Coombes KR; Abruzzo LV; Keating MJ; Calin GA
Blood; 2010 Aug; 116(6):945-52. PubMed ID: 20393129
[TBL] [Abstract][Full Text] [Related]
26. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
[TBL] [Abstract][Full Text] [Related]
27. miR-29c down-regulation is associated with disease aggressiveness and poor survival in Chinese patients with chronic lymphocytic leukemia.
Zhou K; Yu Z; Yi S; Li Z; An G; Zou D; Qi J; Zhao Y; Qiu L
Leuk Lymphoma; 2014 Jul; 55(7):1544-50. PubMed ID: 24138306
[TBL] [Abstract][Full Text] [Related]
28. Bioinformatics-based interaction analysis of miR-92a-3p and key genes in tamoxifen-resistant breast cancer cells.
Cun J; Yang Q
Biomed Pharmacother; 2018 Nov; 107():117-128. PubMed ID: 30086458
[TBL] [Abstract][Full Text] [Related]
29. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-92a-3p Regulates Aggrecanase-1 and Aggrecanase-2 Expression in Chondrogenesis and IL-1β-Induced Catabolism in Human Articular Chondrocytes.
Mao G; Wu P; Zhang Z; Zhang Z; Liao W; Li Y; Kang Y
Cell Physiol Biochem; 2017; 44(1):38-52. PubMed ID: 29241192
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-92a-3p regulates the expression of cartilage-specific genes by directly targeting histone deacetylase 2 in chondrogenesis and degradation.
Mao G; Zhang Z; Huang Z; Chen W; Huang G; Meng F; Zhang Z; Kang Y
Osteoarthritis Cartilage; 2017 Apr; 25(4):521-532. PubMed ID: 27884646
[TBL] [Abstract][Full Text] [Related]
32. Blockage of miR-92a-3p with locked nucleic acid induces apoptosis and prevents cell proliferation in human acute megakaryoblastic leukemia.
Sharifi M; Salehi R
Cancer Gene Ther; 2016 Jan; 23(1):29-35. PubMed ID: 26658357
[TBL] [Abstract][Full Text] [Related]
33. Atherosclerotic Conditions Promote the Packaging of Functional MicroRNA-92a-3p Into Endothelial Microvesicles.
Liu Y; Li Q; Hosen MR; Zietzer A; Flender A; Levermann P; Schmitz T; Frühwald D; Goody P; Nickenig G; Werner N; Jansen F
Circ Res; 2019 Feb; 124(4):575-587. PubMed ID: 30582459
[TBL] [Abstract][Full Text] [Related]
34. miR-92a-3p Exerts Various Effects in Glioma and Glioma Stem-Like Cells Specifically Targeting CDH1/β-Catenin and Notch-1/Akt Signaling Pathways.
Song H; Zhang Y; Liu N; Zhao S; Kong Y; Yuan L
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801803
[TBL] [Abstract][Full Text] [Related]
35. Analysis of LPL gene expression in patients with chronic lymphocytic leukemia.
Bilous N; Abramenko I; Chumak A; Dyagil I; Martina Z
Exp Oncol; 2019 Mar; 41(1):39-45. PubMed ID: 30932419
[TBL] [Abstract][Full Text] [Related]
36. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
Li M; Li BY; Xia H; Jiang LL
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
[TBL] [Abstract][Full Text] [Related]
37. Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
Zhu DX; Miao KR; Fang C; Fan L; Zhu W; Zhu HY; Zhuang Y; Hong M; Liu P; Xu W; Li JY
Leuk Res; 2011 Jun; 35(6):730-4. PubMed ID: 21130495
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
[TBL] [Abstract][Full Text] [Related]
39. CARD11 is a novel target of miR-181b that is upregulated in chronic lymphocytic leukemia.
Kou Z; Mao M; Liu H; Wang X; Wang Z; Gu Z; Lang T; Nie Y; Wang Y; Huang Q; An L; Zhang X; Fu L; Li Y
Biomark Med; 2021 Jun; 15(9):623-635. PubMed ID: 34039026
[No Abstract] [Full Text] [Related]
40. Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment.
Admoni-Elisha L; Nakdimon I; Shteinfer A; Prezma T; Arif T; Arbel N; Melkov A; Zelichov O; Levi I; Shoshan-Barmatz V
PLoS One; 2016; 11(4):e0148500. PubMed ID: 27078856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]